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Abstract
Aquaculture is growing rapidly worldwide than all other food animal producing sectors but the status of 
aquaculture in Ethiopia is less developed, limited data and experience are available.  But still 
widespread belief in the country that the potential will raise with newly increasing water bodies, great 
attention gained from government and opportunities gained for the market because of dramatically 
changing eating habit in the country. A great challenge in the processes of fish production is the 
appearance and development of fish diseases. Vaccination is an important disease management 
strategy used to maintain human and animal health worldwide. Vaccines developed for aquaculture 
have reduced antibiotic use in fish production.  Currently, vaccines are available for some economically 
important bacterial and only few vaccines for viral diseases and no vaccine developed for fish parasites 
and fungus. Major limitations in fish vaccine developments are less understanding of fish immunology, 
many vaccines unlicensed, not cost effective (expensive) and stressful on administration. It is hoped 
that next generation vaccines relied on multiple killed antigens delivered with an adjuvant to enhance 
vaccine effectiveness. The present review will focus on the present status of fish vaccination for 
controlling fish diseases, and shows the needs and directions for future investigations.
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INTRODUCTION 
Fisheries are based on complex resources which include 
hundreds of kinds of fish. Each species has its own 
habits, living in different kinds of water, has different 
market qualities but together they provide excellent 
protein-rich food in far greater variety than animal 
agriculture (Bone et al., 1995).
Aquaculture is growing rapidly worldwide than all other 
food animal producing sectors (Sommerse et al., 2005). 
The production has increased from representing 9% of 
the fisheries resources in 1980 to a current 43%, actually 
and, it is thought that production will need to double in the 
next 25 years (Bensussan et al., 2012). According to 
Bensussan et al. (2012), world food and agriculture 
organization (FAO) promotes aquaculture not only for 
being an important source of money, but also for its great 
contribution to food security and social development of 
many countries.
In all farms of intensive culture, where single or multiple 
species of fishes are reared at high density, optimal 
husbandry and general management-including 
biosecurity, nutrition genetics, system management and 
water quality –are critical for aquatic animal production 
(Bone et al., 1995). However, there are some important 
challenges to develop productive, feasible and 
sustainable aquaculture which are associated with all 
facilities above vulnerable to disease outbreaks because 
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many pathogenic organisms are opportunistic and 
present in environment, or may be found on some fish 
that are not showing signs of disease (carriers) (Roberts, 
1978; Woo et al., 2002; Komar et al., 2004).  
The appearance and development of a fish disease 
process is the result of the interaction between pathogen, 
host and environment. Therefore, only multidisciplinary 
studies involving of the characteristics of the potential 
pathogenic microorganisms for fish, aspects of the 
biology of the fish hosts, as well as a better 
understanding of the environmental factors affecting 
them, will allow the application of adequate measures to 
prevent and control the main diseases limiting the 
production of culture fish (Toranzo et al., 2009). 
Prevention and Control of fish Diseases in Aquaculture 
is high priority in aquaculture industry. Unlike treating 
human or other animal diseases, few drugs are available 
for treating diseases in fish.  Therefore, Control of 
diseases in aquaculture and fish farms relies on a 
combination of good management practices, use of the 
few approved and commercially available drugs and 
vaccines and prevention of infection (Nicholson, 2006).     
Vaccination is becoming an increasingly important part 
of aquaculture, since it is considered a cost effective 
method of controlling different threatening diseases. The 
term vaccination strategy has been defined to include the 
decision as to which diseases to vaccinate against, as 
well as the vaccine type, vaccination method, the timing 
of vaccination and the use of revaccination (Toranzo et 
al., 2009). Therefore, the objective of this paper is: To 
review on present status of fish vaccination for controlling 
fish diseases and show the needs and directions for 
future investigations.
REVIEW OF THE FISHERS AND AQUACULTURE 
SECTOR IN ETHIOPIA
Ethiopia, a land locked country, depends on its inland 
water bodies for fish supply for its population. The water 
body covers only 0.7% of the area of the country and 
comprises 10 lakes in the central highlands, mostly in the 
rift valley, with a total area of 7500km2(FAO, 1995). But 
the newly created water bodies such as dam reservoirs 
and ponds which was estimated to occupy a total area of 
approximately 700 km2 until the early 1995 (Tesfaye, 
1998), is hoped to increases the coverage for the fish 
supply in the near future.
There are over 200 species of fishes are known to occur 
in lakes, rivers and reservoirs in Ethiopia, while the bulk of 
production is made of Nile Tilapia, Catfish, Labeobarbus,  and 
common Carp  species. Approximately 80% of the catch is 
Tilapia, although Nile perch is caught in large quantities on 
lakes Chamo and Abaya, as well as in major riverine 
fisheries. Most of remainder of the lake catches consists 
of Catfish and Barbus (FAO, 1995). Although there is no 
recent study done or documented data giving information, 
the bulk of catches originates from four major lakes: Tana 
(25%), Ziway and Langano (19%), Chamo (18%) and 
Abaya (12%) of the national total population (FAO, 1995). 
Recently the data of Ministry of agriculture and rural 
development (MoARD, 2011) stated that the total catch of 
fishes increase from 14,000 in 1998 to 24257 in year 
2011.  Therefore, there is widespread belief in the 
country that potential exists to raise the annual 
production to over 65,000 tons per year possibly through 
the development of new constructed reservoirs such as 
Tendaho reservoir, Takaze dam reservoir, Gilgel Gibe III 
dam reservoir, and also the great renaissance dam 
reservoir, under exploited river fisheries and aquaculture( 
MoARD, 2011). For instance, the annual demand in the 
year before 2005 was recorded 65,544 tones, equivalent 
to 1kg per person (Abraham, 2005). 
Socio-culture patterns show that there is weak fishing 
tradition and particularly little fish marketing (Tesfaye, 
1998). Due to the dominant Ethiopian Orthodox Church 
which encourages the eating of fish during fasting 
seasons, has served to concentrate domestic fish 
demand only about 80 days of the year: two months 
February and April and two weeks in August. But, 
according to MoARD(2011) in recent years consumers in 
urban area would eat more fish regularly if supplies were 
regularly throughout the year because Ethiopian’s food 
habits is encouraging to substitute more meat for fish.
For instance, nowadays fish has become more and more 
available in most of the private restaurants and hotels.   
In addition, the fisheries in the rift valley lakes and Lake 
Tana have become a dynamically developing sector of 
the food industry, employing well over 3000 fisher folks 
(Abebe, 2008). 
However, the current trends indicate that investment in 
the sector was being recorded in the country although the 
growth of aquaculture was perceived to be relatively 
slow. Fish farming had great potential for reducing 
poverty in the country by increasing fish production for 
food security and income generation amongst 
households, thereby contributing directly to the 
achievement of the Millennium Development Goals 
(MDGs) (MOT, 2011). Through coordinated support to 
the sector it was possible for fish farming to grow to 
unprecedented levels. 
Table1: Annual fish production in year 2011.
Species Production 
per tones 
Value in 
birr”000”
Tilapia 16262 312,602
African 
Catfish
3279 29,154
Barbus 1843 13,324
Common 
carp
929 4,941
Nile perch 844 36,735
Beso 57 456
Bargus 43 2,288
Crucian 
carp
25 133
Aquaculture 16 68
Tilapia
Aquaculture 
trout
0.12 8
Grand Total 24,257 405,448
Source: (MoARD, 2011)
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Basis of Fish Vaccination (the immune response)
The immune system is to protect the fish from bacteria, 
parasite, fungi, virus, or any foreign antigen 
(protein).Therefore, before attempting any vaccination 
strategy, it is important to determine when the immune 
system is both morphologically and functionally mature 
(Toranzo et al., 2009). Fish immunology has a more recent 
history than human and veterinary immunology but the 
techniques used are similar. However, methods of 
administering vaccines to fish differ and are dependent upon 
species, pathogen, temperature and environment 
(Anderson, 1974). 
  
Innate Immune System 
Innate mechanisms require no previous exposure to the 
particular agent- this includes: physical barriers such as 
skin and mucus layers (Anderson, 1974), specialized 
cells such as macrophages and natural killer cells and 
particular soluble molecules such as complement and 
interferon (Ellis, 1978; Ingram, 1979; Ruma, 2006).
The first lines of defense of fish, which have against 
foreign agents, are mucus and skin, which contain 
immune-reactive molecules (i.e., lysozyme, complement 
and immunoglobulin) (Sebastián et al., 2012). Apparently, 
antibody is not produced in the serum but rather 
produced locally by mucosa-associated lymphoid tissues, 
which are sub-divided into gut, skin and gill (Bensussan 
et al., 2012).  Non-specific cells of the fish immune 
system include monocytes or tissue macrophages, 
granulocytes (neutrophils) and cytotoxic cells (Sebastián 
et al., 2012).
As far as the complement is concerned, duplication and 
diversification of several complement components is a 
striking feature of bony fish complement systems. Recent 
studies have also confirmed the presence of functional 
homologues of mammalian cytokines in fish (Sebastián et 
al., 2012).  
The Adaptive Immune System
Fish are a heterogeneous group divided into three 
classes: Agnatha (jawless fish such as the hagfish and 
lampreys), Chrondrichthyes (cartilaginous fish such as 
sharks, rays and skates) and Osteichthyes (bony fish) 
(Sebastián et al., 2012). Fish above the level of the 
Agnatha display typical vertebrate adaptive immune 
responses characterized by immunoglobulins, T-cell 
receptors, cytokines, and major histocompatibility 
complex molecules. However, the immune system of fish 
is quite different in its efficiency and complexity from that 
of higher vertebrates (Leuraud and Boudinot, 2009). 
Acquired immunity in fish includes both humoral and cell 
mediated response. The cell-mediated response in fish is 
similar to that in mammals and relies on the presence of 
antigen results in a cascade of events that includes 
cytokine production that regulates or enhances the 
cellular response (Ruma, 2006).  
Most generative and secondary lymphoid organs in 
mammals are also found in fish, except for lymphatic 
nodules and bone marrow (Sebastián et al., 2012). The 
anterior portion of teleost fish (modern branch of bony 
fishes) kidney is most likely the source of 
histocompatibility complex molecules that will later give 
rise to the B and T-cell development takes place in the 
thymus of all vertebrates based upon an assortment of 
criteria. In teleost fish, progenitor T-cells migrates from 
the kidney to the thymus for T-cell education 
(distinguishing self from non-self) and maturation 
(functional). B-lymphocytes originate and mature within 
the kidney; therefore the anterior region of the fish kidney 
is considered to be evolutionary of the marrow. B-cells of 
fish produce antibody when stimulated (Ruma, 2006).
  
FACTORS AFFECTING THE EFFICACY OF 
VACCINATION
Types of Fish Vaccine Formulation 
Bacterins 
Most bacterial vaccines in aquaculture to date have been 
inactivated vaccines obtained from a broth culture of a 
specific strain(s) subjected to subsequent formalin 
inactivation (Toranzo et al., 1997). Bacterins stimulate the 
antibody related portion of the immune responses (i.e., 
the humoral immune responses) (Roy, 2011). Whereas 
with some vaccine acceptable levels of protection are 
achieved with aqueous formulations administered by 
injection or immersion, for other bacterins, such as those 
devised for Salmonids against Aeromonas salmonicida 
subsp.salmonicida, an acceptable level of protection can 
only be achieved by immunization with oil-adjuvanted 
bacterins delivered by injection (Toranzo et al., 2009).
 
Live Attenuated Vaccines 
Live, attenuated vaccines are composed of live 
microorganisms (bacteria, viruses) that have been grown 
in culture and no longer have the properties that cause 
significant disease (Roy, 2011). These vaccines 
potentially have many advantages in aquaculture. If the 
vaccinated fish shed the vaccine strain an effective 
dissemination of the antigen in the population would take place 
over an extended period. They also have the advantage that 
they stimulate the cellular branch of the immune system 
(Toranzo et al., 2009). Some live vaccines have been 
tested experimentally: Aeromonas salmonicida, 
Edwardsiella tarda, E. ictaluri, Ph.damselae subsp. 
Piscicida. However, problems concerning safety, 
persistence in the fish and in the environment, reversion 
to virulence, risk of spreading to non-target animals 
including wild fish, among others, must be resolved 
before the use of these live attenuated   strains   can   be 
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allowed in the field. At present, only an E. ictaluri 
attenuated live vaccine has been licensed in the USA to 
be used by bath in -9 day old fish to prevent ESC of 
catfish (Toranzo et al., 2009).
DNA vaccines 
DNA vaccines are composed of a particular portion of 
genetic material that can, after being incorporated into 
the animal, produce a particular immune-stimulating 
portion of a pathogen (i.e. antigen) continuously, thus 
providing an “internal” source of vaccine material (Roy, 
2011).
DNA vaccines have theoretical advantages over 
conventional vaccines: in mammals, the specific immune 
response after DNA vaccination encompasses 
antibodies; T-helper cells and cytotoxic cells. However, 
before DNA vaccines are applied in commercial 
enterprises in aquaculture, safety for the fish, 
environment and consumer have to be addressed. As the 
DNA-sequence encodes only a single microbial gene, 
there should be no possibility of reversion to virulence, 
which is a critical factor in relation to environmental safety 
in aquaculture (Toranzo et al., 2009).      
It has been demonstrated that DNA vaccination 
induces a strong and protective immunity to some viral 
infections in fish, particularly the Rhabdoviruses infecting 
rainbow trout and Atlantic salmon, and also for channel 
catfish herpes virus infection (Nusbaum et al., 2002).
Polyvalent Vaccines 
The ideal vaccine formulation is a polyvalent vaccine, 
which protects simultaneously against the majority of the 
diseases to which a particular fish species is susceptible 
(Busch, 1997).
In addition, these polyvalent vaccines must cover all 
the main serotypes of each pathogen existing in a 
particular geographical area. Examples of the efficacy of 
polyvalent vaccines are those used in Salmonids and 
Turbot in which polyvalent vaccines give similar or 
superior protection than the respective monovalent 
vaccines. However, care must be taken in the formulation 
of polyvalent vaccines because the problem of antigen 
competition can occur, especially when these vaccines 
are administered by injection (Busch, 1997; Toranzo et 
al., 2009). 
Route and Strategy of Administration 
Fish are cold- blooded animals with a body temperature 
that equals their surrounding (Bone et al., 1995). 
Depending upon fish species and temperature, 
vaccination must be performed within a certain minimum 
period before the risk of their exposure to pathogens. In 
addition to temperature, stress caused by environments, 
crowding, handling and transport, can induce immune 
suppression and be a limiting factors for vaccine efficacy 
(Sommerse et al., 2005). 
Fish are commonly immunized by three procedures: 
intraperitoneal injection (ip), immersion in a diluted 
vaccine solution (short or long bath), or oral 
administration of the vaccine (Komar et al., 2004).
Although these methods have different advantages and 
disadvantages with respect to the level of protection, side 
effects, practicality and cost-efficiency, it is widely 
accepted that only the  injection and immersion routes 
give enough protection to be used as the primary route of 
fish immunization in commercial production (Evensen, 
2009). 
For oral vaccination, research has been focused on 
protecting the antigens from digestion and decomposition 
during passage through the stomach and anterior part of 
the gut. However, promising results have been obtained 
using encapsulation of antigens in alginate or polylactic 
glycolic acid micro- particles. From the economic stand 
point, oral vaccination is the ideal route to be employed in 
a vaccination program which requires one or more 
booster immunizations (Lin et al., 2005; Toranzo et al., 
2009; Lee et al., 2012).
CURRENT STATUS OF FISH VACCINES  
Bacterial Vaccines
Vaccination plays an important role in large-scale 
commercial fish farming and has been a key reason for 
the success of salmon cultivation. In addition to salmon 
and trout, commercial vaccines are available for channel 
catfish, European seabass and seabream, Japanese 
amberjack and yellow tail, tilapia and Atlantic cod. In 
general, empirically developed vaccines based on 
inactivated bacterial pathogens have proven to be very 
efficacious in fish (Sommerse et al., 2005).
Furunculosis (Ulcerative disease of goldfish, 
Aeromonas salmonicida)
Furunculosis is diseases of fish caused by Aeromonas 
salmonicida subsp. Salmonicida which is facultative 
anaerobic, non-motile, non-spore forming and gram 
negative rod (Bowser 1999; EC, 2003 and Moeller, 2005) 
and, it can also affect fish from fry right through to brood 
stock, and the disease is often triggered by sharp rises in 
water temperatures combined with changes in fish 
physiology such as mollification or spawning (Woo et al., 
2002).
Although many Furunculosis Bacterins have been 
developed and commercialized since 1980, to be used in 
Salmonids by injection, immersion or the oral route their 
efficacy has been questioned because of the lack of 
repetitive results and/or the short protection period. The 
best results in terms of protection have been reported in 
Salmonids with the mineral oil-adjuvanted vaccines but it 
adherent to the viscera and a reduction in weight gain. To 
avoid these drawbacks, new non-mineral   oil-adjuvanted 
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vaccines have been recently developed and are now on 
the market (Toranzo et al., 2009).  Polyvalent vaccines, 
for Salmonids incorporating different Vibrio species and 
A.salmonicida as an antigens, are also available. DNA 
vaccines also were employed experimentally as safe live 
vaccines with a high level of success against 
Furunculosis but their approval for use in the field has not 
yet been forthcoming (Toranzo et al., 2009).
Vibriosis
Vibriosis is one of the most important groups of bacterial 
diseases of marine fish with a worldwide distribution. 
Within the genus Vibrio, the species causing the most 
economically serious diseases in marine culture are 
Vibrio anguillarum, V.ordalii, V.salmonicida and 
V.vulnificus biotype 2 (Woo and Bruno, 1999). 
Vibrio anguillarum, which is the cause of Vibriosis, has 
up to 23 O serotypes (O1-O23) are known only serotypes 
O1, O2 and to a lesser extent, serotype O3, have been 
associated with mortalities (Bowser, 1999; Woo et al., 
2002).
Although there are a great number of commercial Vibrio 
anguillarum vaccines have been developed for use 
mainly by bath or injection (Newman, 1993; Toranzo  et 
al., 2009), the majority of them includes in their 
formulations only O1,or mixture of serotypes O1 and 
O2a. However, different polyvalent oil-adjuvanted 
vaccines, including different combinations of Vibrio 
anguillarum with other pathogens, such as V.ordalii, 
V.salmonicida, Aeromonas salmonicida, Moritella viscose 
and infectious pancreatic necrosis virus, are also 
available on the market to be used for Salmonids by the 
intra-peritoneal route( Toranzo  et al., 2009).
Enteric septicemia of catfish (Edwardsiella ictaluri)
Edwardsiella ictaluri is the entero-bacterium responsible 
for enteric septicemia of catfish, with channel catfish 
being the most susceptible fish species among the 
ictalurids (European Commission, 2003).
The bacterium is gram-negative, motile, pleomorphic 
curved rod (Moeller, 2005), causing a major problem 
during the summer months when water temperature are 
below 18-28oC (EC, 2003).
The first commercial Bacterins for Edwardsiella ictaluri 
were licensed to be used by immersion or oral routes. 
However, Edwardsiella ictaluri is an intracellular 
pathogen for channel catfish; it is not unusual that killed 
vaccines have not been very successful (Toranzo et al., 
2009). Recently, an attenuated O-antigen deficient 
Edwardsiella ictaluri strain has been developed which 
was safe and provided high long-lasting acquired 
immunity (for at least 4 months) following a single bath 
immersion in 9-14 days old channel catfish without 
booster vaccination (Klesius and Shoemaker, 1998). This 
modified live Edwardsiella ictaluri vaccine has been 
produced since 2000, by Intervet Inc., under the trade 
name AQUAVAC-ESCO, and constitutes the first 
licensed bacterial live vaccine in aquaculture formulated 
with an attenuated pathogenic strain (Toranzo et al., 
2009). 
Columnaris disease (saddle back disease, 
Flexibacter columnaris)
Columnaris disease is a sub acute to chronic disease in 
natural infections of most fresh water fishes affecting 
mainly ictalurids, eels, Salmonids, cyprinids, centrarchids 
and ornamental fish such as golden shiner and goldfishes 
(Post, 1987; Toranzo et al., 2009).
Several vaccination experiments against F.columnare 
have been performed on several fish species using 
different routes of administration (i.e. injection, bath and 
oral) but the results in field trials were inconsistent, 
possibly due to the intimate association of stress with the 
disease process. Therefore no commercial vaccines are 
available (Newman, 1993; Toranzo et al., 2009).
Enteric Red mouth disease (Yersiniosis)
Enteric Red mouth disease is caused by Yersinia ruckeri, 
that is,  facultative anaerobic, non-motile, non-spore 
forming and Gram-negative rod (EC, 2003), is mainly a 
fresh water disease of Rainbow trout, although it can 
affect other fish species such as Atlantic salmon in the 
fresh water phase and occasionally even at sea (Moeller, 
2005). 
The common vaccine commercially available recently is 
formalin inactivated whole cell cultures of Y. Ruckeri 
serovar I, Biotype 1 (Hagerman strain) (Toranzo et al., 
2009).
Bacterial kidney disease (Renibacterium 
salmoninarum)
Bacterial kidney disease (BKD) is caused by the Gram-
positive diplobacillus group Renibacterium salmoninarum 
which is a fastidious, aerobic, non-motile, non-spore 
forming, gram-positive short rod bacterium (Woo and 
Bruno, 1999).
Although vaccination trials using classical Bacterins, 
recombinant vaccines or attenuated live vaccines have 
been reported and there is evidence that under some 
conditions Renibacterium elicits an immune response in 
fish (Newman, 1993; Toranzo et al., 2009), the protective 
ability of a vaccine in field conditions is questionable 
because of the intracellular nature and vertical 
transmission of the pathogen, as well as the possible 
immunosuppressive role of the protein p57 (Wood and 
Kaattari, 1996).
Recently, a commercial aqueous live vaccine 
developed by Novartis has been licensed under the name 
of “Renogen” for BKD prevention (Toranzo et al., 2009).
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Mycobacteriosis (fish tuberculosis)
Mycobacteriosis in fish (or fish tuberculosis) is a sub 
acute to chronic wasting disease known to affect nearly 
200 freshwater and saltwater species (Bowser, 1999). 
Although Mycobacterium marinum, which is slow 
growing, non-motile, gram positive and acid fast rods, is 
considered the primary causative agent of fish 
Mycobacteriosis (Toranzo et al., 2009).
According to Toranzo et al. (2009), at present no 
vaccines are available to prevent this disease in fish.
Cold water disease or rainbow trout fry syndrome 
(RTFS)
Flavobacterium psychrophilum (syn., Cytophaga 
psychrophila and Flexibacter psychrophilus) has been 
known as the causative agent of bacterial cold-water 
disease (BCWD) or peduncle disease in Salmonids since 
1948. The same bacterium has been shown to be the 
agent involved in the rainbow trout fry syndrome (RTFS) 
since the decade of the 1 980s (Toranzo et al., 2009). 
Recent vaccination experiments performed with young 
rainbow trout demonstrated that only significant 
protection was achieved using oil-adjuvanted ip vaccines; 
however, this route is impracticable for the early life fish 
stages in which F. psychrophilum infections usually 
occur. In addition, no cross protection among serotypes 
was obtained (LaFrentz et al., 2002). Although no 
commercial vaccines against this disease are available, 
some countries are using autogenous bacterins made 
from single farm isolates (Toranzo et al., 2009).
Pseudomonadiasis
Among the Pseudomonas species recovered from 
diseased fish (P. chlororaphis, P. anguilliseptica, P. 
fluorescens, P. putida, P. plecoglossicida), Pseudomonas 
anguilliseptica is considered the most significant 
pathogen for cultured fish (Toranzo and Barja, 1991).
Recent research efforts led to the development of 
aqueous and non-mineral oil-adjuvanted bacterins 
(including both major serotypes detected), which proved 
to be effective in experimental trials in gilthead sea bream 
and turbot (Toranzo et al., 2009).
Viral Vaccines
In spite of the amount of research performed, both in 
commercial companies and in academic organizations, 
few viral vaccines are licensed. As of today, all fish virus 
vaccines for sale are based upon inactivated virus or 
recombinant proteins. No live attenuated or DNA 
vaccines are currently licensed, but one DNA vaccine 
against IHN (Infectious hematopoietic necrosis) disease 
is being tested in controlled field trials in Canada (Biering 
et al., 2005). Today, most available virus vaccines for 
aquaculture are based on inactivated virus or 
recombinant subunit proteins (Sommerse et al., 2005). In 
activated /killed viral vaccines are generally not 
efficacious unless delivered by injection, and as 
relatively, high doses are needed to achieve protection, 
cost-effective inactivated viral vaccines are difficult to 
develop.
Live viral vaccines have been tested with good results 
in fish and should be the optimal regarding protection and 
should be the optimal regarding protection, administration 
and price (Biering et al., 2005).
Infectious Pancreatic Necrosis
Infectious pancreatic necrosis is a viral disease caused 
by an aquatic Birnavirus. This virus is related to infectious 
bursal disease (IBD) of poultry and in some studies the 
two viruses were morphologically indistinguishable (Woo 
et al., 2002).
The virus can cause problems in both fresh water and 
in the seawater phase of fish rearing. It tends to be a 
disease of younger fish, but the carrier status can exist 
which can give challenges in the control of the disease, 
especially in deciding where to transfer fish. 
There is a vaccine available for Atlantic salmon in the UK 
under a Provisional Marketing Authorization (PMA) 
(Sommerse et al., 2005).
Pancreas Disease (Salmon pancreas disease virus)
Pancreas disease is caused by an alpha virus, Salmon 
pancreas disease virus, which is very closely related to 
the virus causing sleeping disease of Rainbow trout. 
Although the disease is being controlled by bio-
security, it is still a risk for trout growers. There is a 
Salmon pancreas disease vaccine available under a PMA 
(Sommerse et al., 2005), but unlike all the other 
combination Salmon vaccines designed for administration 
in a single injection this has to be given separately from 
any other injectable vaccine. To date there is not yet any 
vaccine available for trout.
Fish Vaccines against Parasites
There is wide range of parasites in both wild and cultured 
fish stocks. Although parasitic diseases such as amoebic 
gill disease, white spot disease, whirling disease, 
proliferative kidney disease (PKD) and Salmon lice 
infestation create several problems in fish farming (Woo 
et al., 2002), no parasite vaccines are commercially 
available (Sommerse et al., 2005). In general, fish posses 
both humoral and cell-mediated defense mechanisms 
against many parasites and there are many reports on 
immunity/ increased resistance among fish surviving 
natural parasitic infection (Ellis, 1978). 
Cultivation of parasites for potential killed or live 
vaccine is even more expensive than virus cultivation 
(Sommerse et al., 2005), as a host population rather than 
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cell cultures are usually required. In addition to the high 
costs, the use of natural hosts for cultivation of parasite 
would create major problems with respect to safety 
documentation.
Therefore, identification and production of protective 
antigens is probably the most feasible strategy towards 
commercial parasite vaccines, at least for low cost 
vaccines.
Limitations in Fish Vaccine Development
The major goal of vaccination is to induce a specific long-
term protection against a certain disease. It has been 
debated whether the effective long term protection of oil-
adjuvant injection vaccines (Evensen et al., 2005), is due 
to immunological memory in the fish or constant 
stimulation from the antigen depot. As the existing 
empirically developed vaccines can induce protection 
after a single administration and until the fish are 
harvested, less effort has been put into the investigation 
of the actual mechanisms behind the protection 
(Sommerse et al., 2005).
As with all veterinary vaccines, cost effectiveness in the 
field is an essential limitation to commercial fish vaccine 
development. The ideal viral vaccine for aquaculture 
must be effective in preventing death, be inexpensive to 
produce and license, provide immunity of long duration, 
and be easily administered (Leong et al., 1997). But fish 
generally need a large antigen dose compared with 
terrestrial animals and cost-effective inactivated viral 
vaccines have proven difficult to develop. In some 
species, even all types of injection vaccines (or even 
immersion vaccines) are simply too expensive 
(Sommerse et al., 2005).
In the past ten years, commercial vaccine products 
for fish have more often consisted of mixtures of multiple 
products, including two, three, four and five vaccine. 
Considering the fact that not all antigens stimulate a 
protective immune response, that antigens vary in their 
immune-dominance relative to each other and that the 
immune system of fish has a defined and limited capacity 
to respond to individual antigenic substances, it becomes 
increasingly difficult to formulate these complex mixtures 
into safe and effective commercial products (Busch, 
1997).
The other limitation is many fish species are too 
vulnerable to handle the stress induced during the 
vaccination or may develop severe side effects post 
vaccination for this matter, Oral vaccination should be 
considered as the most desirable method for 
immunizing fish because it is non-stressful, user-friendly 
and is capable of easy administration to large numbers 
of fish (Lin et al., 2005)  
Most of the research on fish vaccines has been 
performed by pharmaceutical companies, and not much 
information is available as scientific publications 
(Sommerse et al., 2005).
Yet, in other species, the major disease problems may 
appear in the larval or fry stages (Bowser, 1999), before 
the animal is large enough to be vaccinated or have even 
developed functional immune system. The apparent lack 
of maternal immunity in fish also limits the possibilities to 
protect offspring by parental vaccination.
Future Prospects of Fish Vaccination 
During the past 20 years fish vaccines have become an 
established, proven, and cost-effective method of 
controlling certain infectious diseases in aquaculture 
worldwide. Fish vaccines can significantly reduce specific 
disease-related losses resulting in a reduction of 
antibiotics use. 
To achieve progress in fish Vaccinology, an increase in 
the co-operation between basic and applied science (i.e., 
between the immunologist/microbiologist and the 
vaccinologist) is needed. 
There have been greatly advanced in the completion of 
genomic sequencing of pathogens, the application of 
comparative genomic and transcriptome analysis. This 
would facilitate to open opportunities up to investigate a 
new generation of vaccines; recombinant subunit 
vaccine, virus-like particle, DNA vaccine, and vector-
vehicle vaccine. Currently, such types of vaccines are 
being actively explored against various fish diseases 
which depend on biotechnology (Leong et al., 1997), 
affording numerous advantages over conventional 
vaccines, including ease of production, immunogenicity, 
safety, and multivalency in a single shot (Lee et al., 
2012). 
Improvement in oral immunization with biodegradable 
micro particle based vaccines to be used for booster 
vaccination (Toranzo et al., 2009), development of new 
non-mineral oil adjuvants lacking side effects, 
development of polyvalent vaccines and standardization 
of a vaccination calendar appropriate for each 
economically important fish species with molecular 
biology and modern technologies are combining to make 
possible novel approaches to vaccine development 
(Toranzo et al., 2009).
Since resolution of virus persistence is thought to be 
correlated with cell-mediated immunity, vaccines 
designed to augment the cell-mediated immunity must be 
developed for fish. Approaches that are being considered 
include the use of cytokines in combination with subunit 
vaccines and the use of specific MHC-I inducer adjuvants 
with the vaccine (Leong et al., 1997).
There are a number of potential vaccines for many fish 
diseases in aquaculture and Toranzo et al. (2009) study 
also indicated that so many studies have been performed 
or are in progress to formulate vaccines to prevent these 
diseases.
  
CONCLUSION AND RECOMMENDATIONS
Aquaculture is growing rapidly worldwide than all other 
food animal producing sectors but a great challenge in 
the processes is appearance and development of a fish 
disease. Therefore fish vaccination   becomes   the   best 
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method to control and prevent fish diseases over 
antibiotic treatment.  Development of Fish vaccines is a 
challenging task, in part, due to a variety of pathogens, 
hosts, and the uniqueness of host-susceptibility to each 
pathogen. Currently, vaccines are available for some 
economically important bacterial and viral diseases. But 
Vaccines for protection against parasitic and fungal 
diseases have not yet been developed. Major limitations 
in fish vaccine developments are less understanding of 
fish immunology, many vaccines unlicensed, not cost 
effective (expensive) and stressful on administration. But 
it is hoped in near future vaccine developments may 
benefit from that could be increased knowledge of the 
fish immune system and knowledge of pathogen and 
virulence mechanisms which helps in development of live 
vaccines, improved DNA vaccines, sub unit vaccines, 
poly valent and monovalent vaccines, improved 
adjuvants and Oral delivery systems: Based on the 
above conclusion the following points are 
recommended: 1. The status of aquaculture in Ethiopia 
is less developed, limited data and experience which 
should need to be  improved. 2. New vaccination 
strategies, aquaculture expansion and disease 
investigation center should be initiated in Ethiopia. 3. 
Strong coordination should be created between 
pharmaceutical companies and academic research for a 
better development of live fish vaccines.
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